The Hidden Costs of Tariff Volatility in Biotech: From R&D Delays to Clinical Trial Bottlenecks
Tariff volatility may seem like a distant macroeconomic concern, but for biotech companies navigating complex global supply chains, the impact is both immediate and far-reaching….